Pian Zai Huang released its 2026 interim report. During the reporting period, the company's total operating revenue was 4.573 billion yuan, down 14.98% from the same period last year. Net profit attributable to the parent company was 1.093 billion yuan, down 24.22% year-on-year. Net cash inflow from operating activities was 1.625 billion yuan, up 332.58% year-on-year. The company's latest asset-liability ratio was 18.18%, gross margin was 39.83%, return on equity was 7.48%, and diluted earnings per share was 1.81 yuan. The number of shareholders was 118,700, and the top ten shareholders held 65.62% of the total share capital.
Zhangzhou Pientzehuang Pharmaceutical Co LtdNet profit down 24.22% year-on-year in interim report
